Cardinal Capital Management Grows Position in Utah Medical Products, Inc. (NASDAQ:UTMD)

Cardinal Capital Management lifted its stake in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 17.9% during the third quarter, Holdings Channel reports. The fund owned 18,448 shares of the medical instruments supplier’s stock after purchasing an additional 2,803 shares during the quarter. Cardinal Capital Management’s holdings in Utah Medical Products were worth $1,240,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in UTMD. Los Angeles Capital Management LLC lifted its holdings in Utah Medical Products by 127.0% in the 1st quarter. Los Angeles Capital Management LLC now owns 13,086 shares of the medical instruments supplier’s stock valued at $931,000 after purchasing an additional 7,320 shares in the last quarter. Bridge City Capital LLC boosted its position in Utah Medical Products by 43.4% during the first quarter. Bridge City Capital LLC now owns 4,555 shares of the medical instruments supplier’s stock worth $324,000 after acquiring an additional 1,379 shares during the last quarter. BNP Paribas Financial Markets grew its stake in Utah Medical Products by 123.0% in the 1st quarter. BNP Paribas Financial Markets now owns 8,399 shares of the medical instruments supplier’s stock worth $597,000 after acquiring an additional 4,633 shares during the period. Isthmus Partners LLC raised its holdings in Utah Medical Products by 56.8% in the 1st quarter. Isthmus Partners LLC now owns 35,602 shares of the medical instruments supplier’s stock valued at $2,532,000 after acquiring an additional 12,903 shares during the last quarter. Finally, Vanguard Group Inc. lifted its stake in shares of Utah Medical Products by 7.3% during the 1st quarter. Vanguard Group Inc. now owns 183,141 shares of the medical instruments supplier’s stock worth $13,023,000 after purchasing an additional 12,402 shares during the period. Hedge funds and other institutional investors own 69.60% of the company’s stock.

Utah Medical Products Stock Up 0.9 %

Shares of NASDAQ:UTMD opened at $66.30 on Friday. The company has a market cap of $233.91 million, a P/E ratio of 14.73 and a beta of 0.08. The business has a fifty day simple moving average of $66.78 and a 200-day simple moving average of $67.72. Utah Medical Products, Inc. has a 52 week low of $64.90 and a 52 week high of $87.86.

Utah Medical Products (NASDAQ:UTMD) last posted its quarterly earnings results on Thursday, July 25th. The medical instruments supplier reported $0.98 EPS for the quarter. The company had revenue of $10.40 million during the quarter. Utah Medical Products had a return on equity of 12.41% and a net margin of 33.56%.

Utah Medical Products Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, October 4th. Shareholders of record on Friday, September 20th were paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.81%. The ex-dividend date of this dividend was Friday, September 20th. Utah Medical Products’s dividend payout ratio is currently 26.67%.

Utah Medical Products Company Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.